Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple MyelomaLuciano J. Costa, Parameswaran Hari, Carolyn C. Jackson et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 45